Other Organization Information |
Total number of staff in your organization: |
6 - 10 |
Number of full-time staff who are directly involved with TB: |
6 - 10 |
Number of part-time staff who are directly involved with TB: |
1 - 5 |
Number of volunteers who are directly involved with TB: |
6 - 10 |
|
How did you hear about the Stop TB Partnership: |
Involvement in TB control provision |
If you were informed or referred by another partner of the Stop TB Partnership please tell us who: |
|
Why do you wish join the Stop TB Partnership: |
Network with other partners |
|
Are you a member of a Stop TB national partnership: |
No |
Are you in contact with your national TB programme: |
Yes |
Please tell us how your organization is contributing to your country's national TB control plan: |
LHL International is a member of the National TB control committee. LHL International is e.g. the only organisation developing information material on TB in Norway and we are working closely with the Norwegian health system on TB (training, information etc). |
|
Geographical Reach |
Which country is your headquarters located in: |
Norway |
Which countries do you do operate in: (This includes countries you are conducting activities in) |
Malawi Nepal Norway Russian Federation Sudan United Republic of Tanzania Zambia |
Contribution |
Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: |
TB Care Delivery: We are working on DOTS expansion and Enhancement in Malawi, Zambia, Sudan, Tanzania, Russia and Nepal through partners such as NTP, reasearch organisations and patient organisations. We contribute with funding and technical advise.
Drug-Resistant TB: In Russia and Nepal in particular, through partners.We contribute with funding and technical advise.
TB-HIV: We are working on DOTS expansion and Enhancement in Malawi, Zambia, Sudan, Tanzania, Russia and Nepal through partners such as NTP, reasearch organisations and patient organisations. We contribute with funding and technical advise.
New TB Vaccines: Advocacy, in particular towards Norwegian authorities. We cooperate with Aeras.
Research: In particular in Malawi and Sudan by supporting Reach Trust and Epi-lab. We also cooperate with Liverpool School of Tropical Medicine. |